Quality of stepped-wedge trial reporting can be reliably assessed using an updated CONSORT: crowd-sourcing systematic review
Karla Hemming(University of Birmingham), Caroline Kristunas, Catherine Hewitt(University of York), Mona Kanaan, Clíona McDowell, James Martín(University of Birmingham), Sandra Eldridge(Queen Mary University of London), Vichithranie Madurasinghe, Rafael Gafoor(King's College London), JA Thompson(London School of Hygiene & Tropical Medicine), Robin G. Lerner(Tufts Medical Center), Schadrac C. Agbla, Richard Hooper(Queen Mary University of London), Laura Pankhurst(NHS Blood and Transplant), Katherine Fielding(London School of Hygiene & Tropical Medicine), Mark Pilling(AstraZeneca (United Kingdom)), Paul T. Seed(St Thomas' Hospital), Andrew Forbes(Monash University), Jane Candlish, Mélanie Prague, Steven Teerenstra(Radboud University Nijmegen), Katy E. Morgan, Lauren Bell(Washington University in St. Louis), Simon Bond(Cambridge University Hospitals NHS Foundation Trust), Tracy Pellatt‐Higgins, Eila Watson(Oxford Brookes University), Victoria Cornelius(Imperial College London), Indrani Bhattacharya, Christina Easter(University of Birmingham), Monica Taljaard(University of Ottawa), Ben Jones(Peninsula College of Medicine and Dentistry), Kelly Carroll(Ottawa Hospital), Susan Dutton(Oxford Centre for Diabetes, Endocrinology and Metabolism), Nicholas Magill, Alecia Nickless, Nadine Marlin, Emel Yorganci(Cicely Saunders International), Elizabeth L. Turner, Sally Kerry, Michael J. Grayling, John S. Preisser, Mirjam Moerbeek(Utrecht University), Bruno Giraudeau(Inserm), Clémence Leyrat(London School of Hygiene & Tropical Medicine), Beth Stuart(Queen Mary University of London), Murielle Mbekwe, Claire Chan, Pamela Jacobsen, Julia Forman, L. A. Smith(EES Research (United Kingdom))
Cited by 35
Related Papers
CONSORT 2010 statement: extension to randomised pilot and feasibility trials
|Pilot and Feasibility Studies|2016|3k